Biolase Price to Book Ratio 2010-2023 | BIOL

Historical price to book ratio values for Biolase (BIOL) over the last 10 years. The current price to book ratio for Biolase as of April 23, 2024 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Biolase Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2024-04-23 0.15 0.26
2023-12-31 1.12 $0.57 1.96
2023-09-30 1.86 $2.60 0.72
2023-06-30 7.07 $7.20 0.98
2023-03-31 28.12 $30.99 0.91
2022-12-31 65.00 $63.49 1.02
2022-09-30 243.00 $194.04 1.25
2022-06-30 458.00 $315.32 1.45
2022-03-31 883.00 $333.66 2.65
2021-12-31 975.00 $410.09 2.38
2021-09-30 1598.25 $494.56 3.23
2021-06-30 1745.25 $549.90 3.17
2021-03-31 2107.25 $560.91 3.76
2020-12-31 1041.75 $256.70 4.06
2020-09-30 687.75 $372.34 1.85
2020-06-30 1157.50 $65.01 17.81
2020-03-31 937.50 $-70.63 -13.27
2019-12-31 1381.75 $345.27 4.00
2019-09-30 2350.00 $-121.39 -19.36
2019-06-30 3675.00 $433.55 8.48
2019-03-31 5950.00 $818.66 7.27
2018-12-31 2475.00 $1,261.72 1.96
2018-09-30 5175.00 $1,977.25 2.62
2018-06-30 3025.00 $2,474.88 1.22
2018-03-31 5075.00 $3,044.66 1.67
2017-12-31 5330.00 $3,573.87 1.49
2017-09-30 7535.00 $3,480.22 2.17
2017-06-30 12125.00 $4,163.10 2.91
2017-03-31 16875.00 $3,393.02 4.97
2016-12-31 17500.00 $4,082.12 4.29
2016-09-30 21875.00 $4,821.21 4.54
2016-06-30 14625.00 $4,066.46 3.60
2016-03-31 16375.00 $4,633.13 3.53
2015-12-31 10513.75 $5,350.73 1.96
2015-09-30 11250.00 $5,655.36 1.99
2015-06-30 21750.00 $6,671.26 3.26
2015-03-31 25250.00 $7,980.67 3.16
2014-12-31 32875.00 $9,045.86 3.63
2014-09-30 31125.00 $3,156.57 9.86
2014-06-30 27500.00 $964.17 28.52
2014-03-31 30125.00 $2,991.62 10.07
2013-12-31 35199.01 $2,997.07 11.74
2013-09-30 23662.78 $3,373.80 7.01
2013-06-30 44085.42 $3,142.96 14.03
2013-03-31 48767.33 $3,761.48 12.96
2012-12-31 22555.46 $4,712.47 4.79
2012-09-30 20623.52 $4,020.57 5.13
2012-06-30 23538.70 $4,119.56 5.71
2012-03-31 32550.01 $4,642.62 7.01
2011-12-31 30714.89 $5,043.20 6.09
2011-09-30 35498.97 $5,578.29 6.36
2011-06-30 60219.38 $5,853.40 10.29
2011-03-31 56491.19 $1,833.87 30.80
2010-12-31 20098.72 $-1,480.25 -13.58
2010-09-30 13437.43 $-1,659.83 -8.10
2010-06-30 17342.33 $-612.81 -28.30
2010-03-31 22395.72 $1,283.33 17.45
2009-12-31 21936.32 $3,773.18 5.81
2009-09-30 25956.06 $4,312.29 6.02
2009-06-30 19409.62 $3,666.00 5.29
2009-03-31 10279.06 $2,304.20 4.46
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.005B $0.049B
Biolaw Technology, Inc. is the world's leading dental laser company, is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology and other medical and consumer markets.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $69.294B 18.55
Becton Dickinson (BDX) United States $67.568B 19.62
West Pharmaceutical Services (WST) United States $27.478B 46.45
Cardinal Health (CAH) United States $25.012B 15.03
Align Technology (ALGN) United States $22.637B 45.65
Cooper (COO) United States $17.896B 27.08
Labcorp (LH) United States $17.083B 14.59
Henry Schein (HSIC) United States $9.256B 16.01
DENTSPLY SIRONA (XRAY) United States $6.298B 16.60
Merit Medical Systems (MMSI) United States $4.253B 24.34
Patterson (PDCO) United States $2.321B 11.12
STAAR Surgical (STAA) United States $2.275B 71.61
CONMED (CNMD) United States $2.236B 21.05
Atrion (ATRI) United States $0.704B 36.25
Lifevantage (LFVN) United States $0.078B 12.60
Pro-Dex (PDEX) United States $0.065B 24.72